Section Arrow
AZN.NASDAQ
- AstraZeneca PLC
Quotes are at least 15-min delayed:2024/06/01 00:00 EDT
Last
 78.03
+1.26 (+1.64%)
Day High 
78.12 
Prev. Close
76.77 
1-M High
79.36 
Volume 
4.78M 
Bid
77.84
Ask
78.71
Day Low
77.09 
Open
77.31 
1-M Low
75.43 
Market Cap 
238.02B 
Currency USD 
P/E 37.91 
%Yield 1.86 
10-SMA 77.52 
20-SMA 77.13 
50-SMA 72.4 
52-W High 79.36 
52-W Low 60.47 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
2.03/5.26
Enterprise Value
261.25B
Balance Sheet
Book Value Per Share
12.08
Cash Flow
Cash Flow Yield
0.04
Income Statement
Total Revenue
45.81B
Operating Revenue Per Share
14.35
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
PFEPfizer28.66+0.46+1.63%76.86PE
BMYBristol-Myers Squibb Co41.09+0.84+2.09%11.67PE
MRKMerck & Co125.54+1.01+0.81%138.37PE
ABBVABBVIE161.24+4.93+3.15%46.52PE
JNJJohnson & Johnson146.67+1.39+0.96%21.59PE
Quotes are at least 15-min delayed:2024/06/01 00:00 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, immunology and rare diseases. The majority of sales come from international markets with the United States representing close to one third of its revenue.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.